AI-generated market updates and breaking coverage across our tracked tickers.
Eli Lilly (LLY) shows positive pre-market movement driven by AI partnership with NVIDIA and progress on obesity drug development. Nova Aetus rates LLY as HOLD, suggesting a balanced approach for investors.
